Search results
Jeremy Levin (born 1954) is a South African-born businessman, medical doctor and research scientist. In 2018, Levin was named as one of the most influential figures in the biopharmaceutical industry.
Jeremy M. Levin, D.Phil, MB BChir Chief Executive Officer and Chairman Jeremy Levin, D.Phil, MB BChir, is chairman and chief executive officer of Ovid Therapeutics Inc. (NASDAQ: OVID), a public company developing novel medicines to treat epilepsies and seizure-related disorders.
May 1, 2023 · Jeremy Levin, the professorial executive who has become one of the industry’s loudest voices on matters of social justice, is getting back into business with Sam Waksal, a hit-making drug...
Apr 26, 2024 · Dr. Jeremy Levin. CEO, Ovid Therapeutics. Ovid’s lead candidate, soticlestat, is in phase 3 trials for two rare epilepsy conditions: Dravet syndrome and Lennox-Gastaut syndrome.
Oct 30, 2013 · Monday, Teva Pharmaceutical Industries ($TEVA) and CEO Jeremy Levin said he wasn't weighing a resignation. Today, the Israel-based company announced his imminent departure.
Oct 27, 2023 · When Dr. Jeremy Levin examines his career and the profound influence he’s had on the biopharma industry, his thoughts don’t settle on just the professional accolades. Sure, Levin is CEO and chairman of the neuroscience biotech Ovid Therapeutics.
Sep 6, 2022 · Now, as the founder, chairman and CEO of Ovid Therapeutics, a biopharma company focused on treating brain disorders, Levin has built an “innovative orphan drug company that is poised to make a significant difference in the lives of children with rare epilepsies and other seizure-related disorders.”
Jan 28, 2019 · As the chief executive officer of Ovid Therapeutics, Jeremy Levin has a lot on his plate. Every day Levin walks into the office there are multiple tasks of running a pharmaceutical company focused on developing treatments for rare neurological disorders.
Dec 6, 2018 · View Dr. Jeremy M. Levin’s profile on LinkedIn, a professional community of 1 billion members. Experience: Biotechnology Innovation Organization · Education: University of Oxford · Location...
- Biotechnology Innovation Organization
Dr. Jeremy Levin is the Chairman and CEO of Ovid Therapeutics, Inc. (NASDAQ: OVID) a public company developing novel medicines for orphan and rare diseases of the brain. Dr. Levin has deep experience in the global biopharmaceuticals industry, leading companies and people to develop and commercialize medicines that address medical needs worldwide.
